Specialty Pharmacy
May 17, 2016
Hepatitis C: Pharmacists’ Contribution to Optimizing Disease Management
Hepatitis C virus (HCV) affects more than 3% of the global population, and approximately 160 million people have chronic HCV.
May 17, 2016
Specialty Pharmacy: What’s the Impact on Community Practice?
Community pharmacists were surveyed to determine their awareness of the specialty market.
February 17, 2016
Specialty Medications in the Management of Rheumatoid Arthritis
Rheumatoid arthritis is a chronic, inflammatory, systemic autoimmune disorder characterized by symmetrical, erosive synovitis frequently leading to joint destruction, deformity, and disability.
January 20, 2016
Current Perspectives on Multiple Sclerosis
MS manifests as neurologic signs and symptoms related to declining neuromuscular, sensory, and cognitive function, with a waxing and waning pattern of symptoms and/or continuous disease progression.
January 20, 2016
Muscular Dystrophy: Options for Complication Management
There are nine clearly defined types of muscular dystrophy, each differing in age of onset, clinical symptomology, muscle groups impacted, and associated complications.
January 20, 2016
Getting the Word Out
As the specialty pharmacy market grows, so too should the effort to communicate potential interactions.
December 14, 2015
Ulcerative Colitis
This type of inflammatory bowel disease causes swelling and ulceration of the inner lining of the large intestine and rectum.
October 16, 2015
Preventive HIV Vaccines: Progress and Challenges
Despite the success of standard regimens, antiretroviral therapy is complicated by potential drug-drug interactions, patient nonadherence, and adverse effects.
October 16, 2015
Hepatitis C
There are several drugs for treating hepatitis C that are very effective, and new treatments cause fewer side effects than older drug regimens.
